Oncology
Kent Mouw, M.D., PH.D.
Director, Bladder Cancer Center; Assistant Professor of Radiation Oncology, Harvard Medical School
Boston, MA
Kent Mouw, M.D., Ph.D., is an oncologist at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston specializing in bladder, prostate, and urinary cancers. His clinical expertise encompasses precision cancer treatment and genomic diagnostics, with particular focus on targeted therapies such as PARP inhibitors that exploit individual tumor characteristics. As Director of the Bladder Cancer Center and Assistant Professor of Radiation Oncology at Harvard Medical School, Dr. Mouw has
16+
Years in Practice
Credentials
Education & Training
- University of Chicago (MD)
- Harvard Radiation Oncology Program, Radiation Oncology (Residency)
Clinical Focus
Bladder Cancer
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Massachusetts General Hospital, Boston, MA
Experience
16+ years in practice